<p>Animals were treated as decribed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033626#s2" target="_blank">Methods</a>. A(A′)–F(F′): Representative sections from kidneys with [D(D′)–F(F′)] or without [A(A′)–C(C′)] rapamycin treatment, using anti-ki67 for immunohistochemistry. Ki67 postive cells are labeled with brown staining. High-power micrographs are presented as inserted images (A′–F′). Scale bar: 50 µm. G–H: Quantitative analysis of Ki67+ tubular cells (G) and interstitial cells(H) in representative kidney sections. n = 5 animals for each group. **P<0.01 vs. vehicle-treated groups. NS no significance. Error bars represent S.E.</p
<p>(A) Representative histology of colons from vehicle (Veh.)-treated control animals, rapamycin (Ra...
Renal fibrosis is a hallmark of end-stage renal diseases and of chronic allograft nephropathy (CAN)....
Kidney injury triggers fibrosis, the final common pathway of chronic kidney disease (CKD). The incre...
<p>Animals were treated as decribed above. A(A′)–H(H′): Representative sections of vehicle (A–D:low ...
<p>A–B: Co-immunostainging images of kidney sections from day-1 post-obstruction with administration...
<p>HK2 cells or Animals were treated as described in <a href="http://www.plosone.org/article/info:do...
<p>Animals were treated as described in <a href="http://www.plosone.org/article/info:doi/10.1371/jou...
<p>UUO mice received daily i.p. injections of rapamycin (2 mg/kg of body weight) or vehicle respecti...
Rapamycin is an immunosuppressive drug used to prevent acute allograft rejection in solid organ tran...
Rapamycin, a potent inhibitor of the mammalian target of rapamycin (mTOR) protein kinase, is a well-...
Background: Rapamycin is an immunosuppressive drug with potent antifibrotic activity. We evaluated t...
The aim of this study was to determine the effect of rapamycin on renal ischemia-reperfusion injury ...
Unilateral ureteral obstruction (UUO) is a well-characterized hydronephrosis model exhibiting inters...
Renal fibrosis is a hallmark of end-stage renal diseases and of chronic allograft nephropathy (CAN)....
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of cystic ...
<p>(A) Representative histology of colons from vehicle (Veh.)-treated control animals, rapamycin (Ra...
Renal fibrosis is a hallmark of end-stage renal diseases and of chronic allograft nephropathy (CAN)....
Kidney injury triggers fibrosis, the final common pathway of chronic kidney disease (CKD). The incre...
<p>Animals were treated as decribed above. A(A′)–H(H′): Representative sections of vehicle (A–D:low ...
<p>A–B: Co-immunostainging images of kidney sections from day-1 post-obstruction with administration...
<p>HK2 cells or Animals were treated as described in <a href="http://www.plosone.org/article/info:do...
<p>Animals were treated as described in <a href="http://www.plosone.org/article/info:doi/10.1371/jou...
<p>UUO mice received daily i.p. injections of rapamycin (2 mg/kg of body weight) or vehicle respecti...
Rapamycin is an immunosuppressive drug used to prevent acute allograft rejection in solid organ tran...
Rapamycin, a potent inhibitor of the mammalian target of rapamycin (mTOR) protein kinase, is a well-...
Background: Rapamycin is an immunosuppressive drug with potent antifibrotic activity. We evaluated t...
The aim of this study was to determine the effect of rapamycin on renal ischemia-reperfusion injury ...
Unilateral ureteral obstruction (UUO) is a well-characterized hydronephrosis model exhibiting inters...
Renal fibrosis is a hallmark of end-stage renal diseases and of chronic allograft nephropathy (CAN)....
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of cystic ...
<p>(A) Representative histology of colons from vehicle (Veh.)-treated control animals, rapamycin (Ra...
Renal fibrosis is a hallmark of end-stage renal diseases and of chronic allograft nephropathy (CAN)....
Kidney injury triggers fibrosis, the final common pathway of chronic kidney disease (CKD). The incre...